PCSK9 inhibitors: Ratification of the role of LDL cholesterol in cardiovascular prevention. Towards a convergence of European and North American prevention guidelines? C. Guijarro; M. Camafort;

Failure of LDL-C goals achievement and underuse of lipid-lowering therapies in patients at high and very high cardiovascular risk: Spanish subset from the European SANTORINI study J.M. Mostaza; L. García-Ortiz; M.A. Suárez Tembra; P. Talavera Calle; J. Chimeno García; V. Escolar Pérez; J.L. Díaz-Díaz; L. Manzano-Espinosa; A.L. Catapano; K.K. Ray; G. Díaz Moya; J. Pedro-Botet Montoya;

Clinical characteristics of premature cardiovascular disease in our health area M. Viscasillas; I. Lamíquiz-Moneo; M.R. Pérez-Ruiz; R. Garcia-Fenoll; E. Jarauta;